A strategy for population pharmaceutical quality assessment based on quality by design
From a regulatory perspective, drug quality consistency evaluation must concern different processes used for the same drug. In this study, an assessment strategy based on quality by design (QbD) was developed for population pharmaceutical quality evaluation. A descriptive analysis method based on Qb...
Saved in:
Main Authors: | Yu Zhao (Author), Changqin Hu (Author), Shangchen Yao (Author), Lihui Yin (Author), Xiaomei Ling (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmaceutical "quality by design" approach
by: Upendra Nagaich
Published: (2018) -
Aspects and Implementation of Pharmaceutical Quality by Design
by: Tamás Sovány, et al.
Published: (2024) -
Quality-by-Design Is a Tool for Quality Assurance in the Assessment of Enantioseparation of a Model Active Pharmaceutical Ingredient
by: Dina Aboushady, et al.
Published: (2020) -
Scale-Up Strategy in Quality by Design Approach for Pharmaceutical Blending Process with Discrete Element Method Simulation
by: Su Bin Yeom, et al.
Published: (2019) -
Design of Experiments (DoE) applied to Pharmaceutical and Analytical Quality by Design (QbD)
by: Isa Martins Fukuda, et al.
Published: (2018)